Cochrane Evidence Synthesis and Methods ►

Placebo response and remission rates in randomised trials of induction and maintenance therapy for Crohn’s disease

This review has been withdrawn.

The reason for withdrawal and previous versions are archived and accessible within the withdrawn record in the Cochrane Library.

Health topics:

Child health > Gastroenterology > Inflammatory bowel disease

Gastroenterology & hepatology > Inflammatory bowel disease > Crohn's disease: induction of remission

Gastroenterology & hepatology > Inflammatory bowel disease > Crohn's disease: maintenance of remission

Published:

20 January 2017

Authors:

Jairath V, Zou G, Parker CE, MacDonald JK, Mosli MH, AlAmeel T, Al Beshir M, Almadi MA, Al-Taweel T, Atkinson NSS, Biswas S, Chapman T, Dulai PS, Glaire MA, Hoekman DR, Kherad O, Koutsoumpas A, Minas E, Restellini S, Samaan M, Khanna R, Levesque BG, D'Haens G, Travis S, Sandborn WJ, Feagan BG

See the full Review on

the Cochrane Library

►

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
Jairath V, Zou G, Parker CE, MacDonald JK, Mosli MH, AlAmeel T, Al Beshir M, Almadi MA, Al-Taweel T, Atkinson NSS, Biswas S, Chapman T, Dulai PS, Glaire MA, Hoekman DR, Kherad O, Koutsoumpas A, Minas E, Restellini S, Samaan M, Khanna R, Levesque BG, D'Haens G, Travis S, Sandborn WJ, Feagan BG. Placebo response and remission rates in randomised trials of induction and maintenance therapy for Crohn’s disease. Cochrane Database of Systematic Reviews 2017, Issue 1. Art. No.: CD012288. DOI: 10.1002/14651858.CD012288.pub2